Publication:
Preclinical studies evaluating the therapeutic efficacy of novel natural compound olean-12-en-28-ol, 3β pentacosanoate for multiple sclerosis

Simple item page
dc.contributor.authorŞenol H.
dc.contributor.authorÖzgün-Acar Ö.
dc.contributor.authorDağ A.
dc.contributor.authorEken A.
dc.contributor.authorAcar B.
dc.contributor.authorAktaş Pepe N.
dc.contributor.authorGüner H.
dc.contributor.authorAykut Z. G.
dc.contributor.authorÇevik Kaplan S.
dc.contributor.authorAyaz Güner Ş.
dc.contributor.authoret al.
dc.contributor.institutionauthorŞENOL, HALIL
dc.contributor.institutionauthorDAĞ, AYDAN
dc.contributor.institutionauthorTOPÇU, GÜLAÇTI
dc.date.accessioned2023-02-25T21:30:12Z
dc.date.available2023-02-25T21:30:12Z
dc.date.issued2022-09-26
dc.identifier.citationŞenol H., Özgün-Acar Ö., Dağ A., Eken A., Acar B., Aktaş Pepe N., Güner H., Aykut Z. G., Çevik Kaplan S., Ayaz Güner Ş., et al., \"Preclinical studies evaluating the therapeutic efficacy of novel natural compound olean-12-en-28-ol, 3β pentacosanoate for multiple sclerosis\", I. International Advances in Molecular Biology Congress, İstanbul, Türkiye, 19 - 22 Eylül 2022, ss.55-56
dc.identifier.urihttps://hdl.handle.net/20.500.12645/37115
dc.relation.ispartofI. International Advances in Molecular Biology Congress
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTemel Bilimler
dc.subjectLife Sciences
dc.subjectMolecular Biology and Genetics
dc.subjectNatural Sciences
dc.subjectTemel Bilimler (SCI)
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectDoğa Bilimleri Genel
dc.subjectÇOK DİSİPLİNLİ BİLİMLER
dc.subjectNatural Sciences (SCI)
dc.subjectLife Sciences (LIFE)
dc.subjectNATURAL SCIENCES, GENERAL
dc.subjectMOLECULAR BIOLOGY & GENETICS
dc.subjectMULTIDISCIPLINARY SCIENCES
dc.subjectMoleküler Biyoloji
dc.subjectMultidisipliner
dc.subjectMolecular Biology
dc.subjectMultidisciplinary
dc.titlePreclinical studies evaluating the therapeutic efficacy of novel natural compound olean-12-en-28-ol, 3β pentacosanoate for multiple sclerosis
dc.typeconferenceObject
dspace.entity.typePublication
local.avesis.id7b88bb07-0b29-4ec5-b2eb-0a13eea91926
relation.isAuthorOfPublication1c5c41d3-57c1-4cd3-b92a-b67095184ea9
relation.isAuthorOfPublication5053fdfd-57cd-423a-9076-db4bab8cbe3d
relation.isAuthorOfPublication3c94748e-c303-4294-ad67-c5a0739628e5
relation.isAuthorOfPublication.latestForDiscovery1c5c41d3-57c1-4cd3-b92a-b67095184ea9
Files
Collections
Yayınlar - Eserler